Search Results < Yale Interventional Oncology Research Lab

Yale Interventional Oncology Research Lab

2138 results

News
Comparative effectiveness of group v. individual trauma-focused treatment for posttraumatic stress disorder in veterans
Group cognitive processing therapy (CPT) was associated with a slightly smaller reduction of PTSD symptom severity than individual CPT or prolonged exposure (PE) in veterans at the end of residential treatment. There were no differences at 4-month follow-up.
Source: Psychological Medicine
16 Aug 2022
News
Dave Receives AHA Career Development Award
Jui Dave, PhD, an associate research scientist in the Greif Lab, was awarded a Career Development Award from the American Heart Association.
8 Aug 2022
News
Kabir receives AHA Career Development Award
Inamul Kabir, PhD, was selected for a Career Development Award (2022-2025) from the American Heart Association.
5 Aug 2022
News
Association of Distress Due to Systemic Racism and Racial Disparities With Psychopathology and Suicidal Ideation Among US Veterans During the COVID-19 Pandemic
A team of Yale Psychiatry researchers analyzed data from a national sample of US veterans to examine the prevalence of perceived systemic racism and racial disparities in COVID-19–related health outcomes and the association of racism-related distress with internalizing and externalizing psychopathology and suicidal ideation during the pandemic.
Source: The Journal of Clinical Psychiatry
2 Aug 2022
News
Yale Scientists Identify Genetic Risk Factors for Opioid Use and Related Substance Use Disorders
A new human genomics study led by Yale scientists has identified genetic risk factors for opioid use disorder (OUD) and related substance use disorders according to a new large-scale genome-wide association study – increasing the number of risk genes known from 1 to 19.
26 Jul 2022
News
Understanding how mechanical forces contribute to disease: Dr. Nicolas Baeyens
Dr. Nicolas Baeyens reflects on lessons learned while working with Dr. Martin Schwartz.
21 Jul 2022
News
Yale Study: Opioid Tapering Support Using a Web-based App
Sara N. Edmond, PhD, assistant professor of psychiatry, is first author of a paper in Contemporary Clinical Trials that describes the development and protocols of a web-based program designed to support patients willing to consider an opioid taper.
Source: Contemporary Clinical Trials
21 Jul 2022
News
Yale Researchers Receive ACNP 2022 Travel Award
Two Yale Psychiatry researchers are among the recipients of the American College of Neuropsychopharmacology (ACNP) 2022 Travel Award.
19 Jul 2022
News
Yale study decodes a signaling network that mediates vascular resilience
New research by scientists at Yale’s Cardiovascular Research Center advances the current understanding of the pathways that inhibit inflammation and promote vascular health.
19 Jul 2022
News
The Brain’s Drainage System in 3 Dimensions
Meningeal lymphatic vessels are potential targets to treat brain diseases. Laboratories at Yale and the Paris Brain Institute (Pitié-Salpêtrière Hospital, Paris) image brain drainage by meningeal lymphatics in mice and in humans.
19 Jul 2022
News
Development and Validation of the Psychiatric Inpatient Experience (PIX) Survey: A Novel Measure of Patient Experience Quality Improvement
David Klemanski, PsyD, MPH, assistant professor of psychiatry, recently published a paper about a new survey he created alongside colleagues Todd Barnes and Cynthia Bautista to measure patient experience for inpatient psychiatry. The measure itself is part of a larger project of patient experience measures within Psychiatry and Behavioral Health.
Source: Journal of Patient Experience
28 Jun 2022
News
Yale Researcher Studies Alzheimer's Disease
Dr. Carolyn Fredericks of Yale School of Medicine talks about what is involved when volunteering for brain research on Alzheimer's disease.
13 Jun 2022
News
Bold Receives Grant to Study Impact of Menthol Flavor Ban in Cigarettes and E-cigarettes
Krysten Bold, PhD, assistant professor of psychiatry, has received an R01 grant from the National Institute on Drug Abuse (NIDA) to study the impact of a menthol flavor ban in cigarettes and e-cigarettes to inform tobacco policy.
8 Jun 2022
News
Le Zhang, PhD Wins Avenir Award for Research on Substance Use Disorders and HIV/AIDS
Assistant Professor Le Zhang, PhD was recently awarded a DP2 grant from the National Institutes of Health (NIH), entitled “Immune Network Dysregulation of the Central Nervous System with HIV Persistence and Opioid Abuse.” The grant, which amounts to more than $2.5 million, began on May 15, 2022 and lasts for four years.
24 May 2022
News
From Perceived Stress to Demoralization in Parkinson Disease: A Path Analysis
Researchers at the Yale Departments of Psychiatry and Neurology found that in patients with Parkinson disease, depression, anxiety, and subjective incompetence are mediators between perceived stress and demoralization.
11 May 2022
News
Long-term COVID-19: Tackling Tough Questions About the Body’s Immune Response and Brain Symptoms
As long COVID-19 emerged, here’s what researchers at Yale learned about the body’s immune response and mysterious symptoms affecting the brain.
10 May 2022
News
Sleep’s Crucial Role in Preserving Memory
During sleep, our brains are busy consolidating memories and removing waste to keep our minds sharp. Recent findings from Yale on sleep hygiene and more.
10 May 2022
News
Lab Uncovers Role of Metabolic Signaling in Preventing Atrial Fibrillation
Research from the Yale School of Medicine indicates that a protein kinase that is a master regulator of cell metabolism is critical to preventing atrial fibrillation.
22 Apr 2022
News
Sex Differences in the Acute Effects of Intravenous (IV) Delta‑9 Tetrahydrocannabinol (THC)
Anahita Bassir Nia, MD, assistant professor of psychiatry, and Mohini Ranganathan, MD, associate professor of psychiatry, are first and senior authors, respectively, of a paper in Psychopharmacology that investigated the sex differences in the acute effects of intravenous (IV) delta 9 tetrahydrocannabinol (THC), the main psychoactive compound of cannabis.
Source: Psychopharmacology
20 Apr 2022
News
Priming the Pump: WHRY and Akiko Iwasaki Take the Long View on Research
Dr. Akiko Iwasaki’s efforts to create a nasal spray vaccine that generates an effective immune response to COVID-19 evolved from work first sponsored by Women’s Health Research at Yale almost two decades ago.
11 Apr 2022